ustekinumab biosimilars on Blue Shield Rx Enhanced (S2468-004)
Wezlana, Selarsdi, Pyzchiva and others
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 0.5 per 28 days.
$1,600.17
Patient pays / month
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
USTEKINUMAB 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $4,849.01 for a month.
Prior authRequired on the covered form· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (888)239-6469. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s2468-004